title: Serpentine supravenous hyperpigmentation due to hydroxychloroquine.
authors.affiliation: Northwell Health, Long Island Jewish Medical Center and North Shore University Hospital, Department of Cardiology, Hofstra Northwell School of Medicine, New Hyde Park, NY, USA JLau@northwell.edu.
authors.forename: Joe F
authors.initials: JF
authors.lastname: Lau
authors.affiliation: Department of Cardiovascular Medicine, Davis Heart Lung Institute, Ohio State University Wexner Medical Center, Columbus, OH, USA.
authors.forename: Steven M
authors.initials: SM
authors.lastname: Dean
authors.affiliation: Division of Cardiovascular Diseases, Gonda Vascular Center, Mayo Clinic, Rochester, MN, USA.
authors.forename: Thom W
authors.initials: TW
authors.lastname: Rooke
authors.affiliation: Zena and Michael A. Wiener Cardiovascular Institute & Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
authors.forename: Jeffrey W
authors.initials: JW
authors.lastname: Olin
mesh_terms: D000962:Antimalarials / Q000009:adverse effects*; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects*; D017495:Hyperpigmentation / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged
chemical_list: D000962:Antimalarials; D006886:Hydroxychloroquine